Last updated on September 2018

The Product Surveillance Registry REVERSE Post Approval Study


Brief description of study

The purpose of the REVERSE Post Approval Study (PAS) is to confirm the benefit observed in the REVERSE and RAFT pivotal studies in "real-world" clinical practice.

Detailed Study Description

The REVERSE PAS will estimate the 3-year survival probability of freedom from heart failure hospitalization and heart failure events in patients implanted with a Medtronic CRT-D device who meet the expanded indication criteria with a QRS duration 150 ms.

Clinical Study Identifier: NCT01660035

Contact Investigators or Research Sites near you

Start Over

Medtronic Product Surveillance Registry

Ocean City, NJ United States
2.52miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.